Loading...
Back
BVX
BVX
ABIVAX SA
(ABVX)
2024 6-K
Follow
Summary
Share
Summary
Financial Report
22 May '26
Shareholder Meeting Results
20 May '26
Royalty Buyback Agreement
7 May '26
Preparatory Documents
20 Apr '26
Abivax Results
23 Mar '26
Clinical Efficacy Report
23 Feb '26
Financial Update
15 Dec '25
Financial Update
8 Sep '25
Public Offering Announcement
24 Jul '25
Positive Trial Results
22 Jul '25
Shareholder Meeting Results
11 Jun '25
Q1 2025 Filing
2 Jun '25
Trial Enrollment Complete
29 Apr '25
Board Appointment
22 Apr '25
Financial Results Announced
24 Mar '25
Corporate Disclosure
10 Jan '25
Board Resignation
23 Dec '24
Equity Offering Announcement
19 Nov '24
Key Financial Update
14 Nov '24
Filing Announcement
3 Oct '24
Press Release Issued
3 Oct '24
Filing Report
26 Sep '24
Press Release Issued
25 Sep '24
Filing Announcement
9 Sep '24
Financial Results Update
9 Sep '24
Regulatory Filing Update
6 Aug '24
Filing Update
16 Jul '24
Shareholder Meeting Results
4 Jun '24
Press Release Issued
7 May '24
Company Filing Notice
2 Apr '24
February Filing
2 Feb '24
Filing Summary
22 Jan '24
External Links:
SEC
On February 2, 2024, Abivax S.A. issued a press release reported in the 6-K filing.
AI Assistant
Close
ABIVAX SA
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.